Serum IgM samples by COVID-19 disease severity (mild, moderate, severe) binding to the various SARS-CoV-2 protein antigens compared to no disease (NC). by Marie Le Berre (6299012)

Serum IgG samples by COVID-19 disease severity (mild, moderate, severe) binding to the various SARS-CoV-2 protein antigens compared to no disease (NC). by Marie Le Berre (6299012)

Resuscitation with AVP restores the mean arterial blood pressure. by Carrie A. Sims (4532332)

Synthesis and Reactivity of Heptamethylcyclohexadienyl Rhodium(III) Complexes by Roman A. Pototskiy (8082911)

“…Accordingly, the catalytic reaction of 2-phenylpyridine with 3-hexyne in the presence of <b>4</b> (5 mol %) gave the 9,10-diethyl-8a-azaphenanthrene cation in 61% yield. …”

Molecular Origin of Photovoltaic Performance in Donor-<i>block</i>-Acceptor All-Conjugated Block Copolymers by Kendall A. Smith (1477033)

“…All-conjugated block copolymers may be an effective route to self-assembled photovoltaic devices, but we lack basic information on the relationship between molecular characteristics and photovoltaic performance. Here, we synthesize a library of poly­(3-hexyl­thiophene) (P3HT) <i>block</i> poly­((9,9-dialkyl­fluorene)-2,7-diyl-<i>alt</i>-[4,7-bis­(alkyl­thiophen-5-yl)-2,1,3-benzo­thiadiazole]-2′,2″-diyl) (PFTBT) donor-<i>block</i>-acceptor all-conjugated block copolymers and carry out a comprehensive study of processing conditions, crystallinity, domain sizes, and side-chain structure on photovoltaic device performance. …”

Molecular Origin of Photovoltaic Performance in Donor-<i>block</i>-Acceptor All-Conjugated Block Copolymers by Kendall A. Smith (1477033)

“…All-conjugated block copolymers may be an effective route to self-assembled photovoltaic devices, but we lack basic information on the relationship between molecular characteristics and photovoltaic performance. Here, we synthesize a library of poly­(3-hexyl­thiophene) (P3HT) <i>block</i> poly­((9,9-dialkyl­fluorene)-2,7-diyl-<i>alt</i>-[4,7-bis­(alkyl­thiophen-5-yl)-2,1,3-benzo­thiadiazole]-2′,2″-diyl) (PFTBT) donor-<i>block</i>-acceptor all-conjugated block copolymers and carry out a comprehensive study of processing conditions, crystallinity, domain sizes, and side-chain structure on photovoltaic device performance. …”

Molecular Origin of Photovoltaic Performance in Donor-<i>block</i>-Acceptor All-Conjugated Block Copolymers by Kendall A. Smith (1477033)

“…All-conjugated block copolymers may be an effective route to self-assembled photovoltaic devices, but we lack basic information on the relationship between molecular characteristics and photovoltaic performance. Here, we synthesize a library of poly­(3-hexyl­thiophene) (P3HT) <i>block</i> poly­((9,9-dialkyl­fluorene)-2,7-diyl-<i>alt</i>-[4,7-bis­(alkyl­thiophen-5-yl)-2,1,3-benzo­thiadiazole]-2′,2″-diyl) (PFTBT) donor-<i>block</i>-acceptor all-conjugated block copolymers and carry out a comprehensive study of processing conditions, crystallinity, domain sizes, and side-chain structure on photovoltaic device performance. …”

Molecular Origin of Photovoltaic Performance in Donor-<i>block</i>-Acceptor All-Conjugated Block Copolymers by Kendall A. Smith (1477033)

“…All-conjugated block copolymers may be an effective route to self-assembled photovoltaic devices, but we lack basic information on the relationship between molecular characteristics and photovoltaic performance. Here, we synthesize a library of poly­(3-hexyl­thiophene) (P3HT) <i>block</i> poly­((9,9-dialkyl­fluorene)-2,7-diyl-<i>alt</i>-[4,7-bis­(alkyl­thiophen-5-yl)-2,1,3-benzo­thiadiazole]-2′,2″-diyl) (PFTBT) donor-<i>block</i>-acceptor all-conjugated block copolymers and carry out a comprehensive study of processing conditions, crystallinity, domain sizes, and side-chain structure on photovoltaic device performance. …”

The scatterplot, linear regression equation, 95% confidence band, and <i>p</i>-value for the concentration of arsenic (As) in micrograms per liter (μg/L) versus oxidation-reduction... by Seth H. Frisbie (7821866)

Serum 25(OH)VD3 levels in VD₃ sufficient and deficient mice. by Kavya Annu (11587215)

Proportion of VD₃ sufficient vs. deficient mice surviving from BCR-ABL ALL when treated with dexamethasone. by Kavya Annu (11587215)

DEX oral gavage PK raw data. by Kavya Annu (11587215)

Discontinuous DEX PK raw data from repeated study. by Kavya Annu (11587215)

Cartoon depicting dexamethasone and dasatinib metabolism and efflux transport in intestine and liver. by Kavya Annu (11587215)

Gene expression (qPCR) data from livers of C57BL/6 mice before and after DEX treatment. by Kavya Annu (11587215)

Raw data from survival study in VD₃ sufficient vs. deficient male mice from BCR-ABL ALL when treated with dexamethasone. by Kavya Annu (11587215)

Gene expression (qPCR) data from VD3 sufficient and deficient hCYP3A4 12-week-old mice liver and kidney. by Kavya Annu (11587215)

Gene expression (qPCR) data from VD3 sufficient and deficient C57BL/6 mice duodenum. by Kavya Annu (11587215)

Gene expression (qPCR) data from duodenums of C57BL/6 mice before and after DEX treatment. by Kavya Annu (11587215)

Gene expression (qPCR) data from VD3 sufficient and deficient hCYP3A4 12-week-old mice duodenum. by Kavya Annu (11587215)